.......................My name is Martin Tindall......................... My role as Strategic Advisor and imagineer at OrionIQ.com is to help our clients create and implement solutions to expand their business, profits and social impacts. My philanthropic purpose is to help facilitate sustainable and affordable healthcare solutions for least developed and developing countries.
Martin Tindall's Bio:
Martin Tindall's Experience:
-
Chief Analyst at OrionIQ International Limited
August 2021 - Present | New York, Nassau, Port VilaProviding key clients with services and connections to optimize their business performance and access to key service providers.
-
Founder at Tindall Life
July 2020 - Present | Australia, United States, VanuatuTo do our part in making the world a better place for all. Delivering global good through care and kindness.
-
Benefactor at Global Health Trust
July 2017 - Present | WorldwideThe Global Health Trust was created to provide Governments of the World and their people with access to Healthcare Infrastructure Financing, installation, implementation, and operations, to expand the access to much needed healthcare, infrastructure, equipment, education, training, and support systems. All while providing access solutions to people who can’t afford healthcare and medications or would otherwise die without it. Healthcare is a fundamental human right.
-
Founder at Phoenix Life Sciences International Limited
September 2013 - Present | Denver ColoradoPhoenix Life Sciences International Limited - a Global Health Initiative. Phoenix Life Sciences International Limited is an adaptive healthcare solutions company providing pharmaceutical production of cannabis-based therapeutics for global distribution. Our Vision - Create a future where the human body can restore, repair and rejuvenate itself. Our Current Mission - Create a global platform for the reintroduction of cannabis-based therapeutics into the mainstream of healthcare. My Role - Creating the execution for growth and global execution of Phoenix Life Sciences International plan. Why ? - In 2013, Martin Tindall's father died as a result of ineffective healthcare in the treatment of pancreatic cancer. Today as part of Phoenix Life Sciences, he gets to help create a future with high efficacy, low side effect, plant based compounds.
-
Executive Director at Phoenix Pharms Capital Corporation
October 2013 - September 2018 | Longmont, COMartin Tindall is an Executive Director of Phoenix Pharms Capital Corporation and is responsible for financing and capital management for projects and partnerships in the medical cannabis industry. Following the death of his father in 2013 as a result of chemotherapy treatment for pancreatic cancer, Martin's core goal is the pursuit of alternative treatments for cancer. This has lead to his involvement in the building of Phoenix Pharms Capital Corporation, Phoenix Bio Pharmaceuticals and MediJane Holdings. In this position his key focus is the securing of capital and the formation of strategic alliances.
-
Executive Director at Kronos International Investments Limited
May 2012 - December 2017 | Longmont, COKronos International Investments Limited, represents a global group of enterprises focused on facilitation, incubation, financing, and delivering planned execution of projects and partnerships in the areas of medical marijuana, ecology and energy, multiple land use development, technology, and financial platforms. Martin Tindall's role is the focus on capital raising, and project partnerships.
Martin Tindall's Education:
-
Western Sydney Institute of Higher Education
Concentration: Accounting, Commercial and Company Law -
Galston High 1988-1989
-
Billabong High School
Martin Tindall's Interests & Activities:
Golf, travel, wining and dining, helping people, the environment, alternative energy, property development, plant-based pharmaceuticals including medical cannabis, technology, medicine, healthcare, human health, cancer, diabetes, autoimmune disease and snow boarding.